{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["chemical biology", "drug design and development", "medicinal chemistry", "natural compounds", "new small entities", "organic synthesis", "pharmaceutical analysis", "therapeutic proteins"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29143778", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "02"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "28"}], "Language": ["eng"], "ELocationID": ["1848", "10.3390/molecules22111848"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "11", "PubDate": {"Year": "2017", "Month": "Oct", "Day": "28"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot <sup>\u2020</sup>.", "Abstract": {"AbstractText": ["The 46th EuroCongress on Drug Synthesis and Analysis (ECDSA-2017) was arranged within the celebration of the 65th Anniversary of the Faculty of Pharmacy at Comenius University in Bratislava, Slovakia from 5-8 September 2017 to get together specialists in medicinal chemistry, organic synthesis, pharmaceutical analysis, screening of bioactive compounds, pharmacology and drug formulations; promote the exchange of scientific results, methods and ideas; and encourage cooperation between researchers from all over the world. The topic of the conference, \"Drug Synthesis and Analysis,\" meant that the symposium welcomed all pharmacists and/or researchers (chemists, analysts, biologists) and students interested in scientific work dealing with investigations of biologically active compounds as potential drugs. The authors of this manuscript were plenary speakers and other participants of the symposium and members of their research teams. The following summary highlights the major points/topics of the meeting."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. mucaji@fpharm.uniba.sk."}], "LastName": "Mucaji", "ForeName": "Pavel", "Initials": "P"}, {"Identifier": ["0000-0003-2545-0967"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Postepu 36A, 05-552 Jastrzebiec, Poland. a.atanasov@ighz.pl."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria. a.atanasov@ighz.pl."}], "LastName": "Atanasov", "ForeName": "Atanas G", "Initials": "AG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. andrzej.bak@us.edu.pl."}], "LastName": "Bak", "ForeName": "Andrzej", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Synthesis Chemistry, Faculty of Mathematics, Physics and Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. d.wang@ighz.pl."}], "LastName": "Kozik", "ForeName": "Violetta", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Medicine, Medical University of Silesia, Medykow 18, 40752 Katowice, Poland. robert.musiol@us.edu.pl."}], "LastName": "Sieron", "ForeName": "Karolina", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy Glendale, Midwestern University, 19555 N. 59th Avenue, Glendale, AZ 85308, USA. teresa.kowalska@us.edu.pl."}], "LastName": "Olsen", "ForeName": "Mark", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. wdpan@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang, 550014, China. wdpan@163.com."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. liuyazi19@gmail.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang, 550014, China. liuyazi19@gmail.com."}], "LastName": "Liu", "ForeName": "Yazhou", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. hushengcao0221@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang, 550014, China. hushengcao0221@163.com."}], "LastName": "Hu", "ForeName": "Shengchao", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. lanjunjie2007@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang, 550014, China. lanjunjie2007@163.com."}], "LastName": "Lan", "ForeName": "Junjie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, University of Vienna, Althanstra\u00dfe 14, A-1090 Vienna, Austria. smoluch@agh.edu.pl."}], "LastName": "Haider", "ForeName": "Norbert", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. polanski@us.edu.pl."}], "LastName": "Musiol", "ForeName": "Robert", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, 17. listopadu 12, 77146 Olomouc, Czech Republic. jelicav@pharmacy.bg.ac.rs."}], "LastName": "Vanco", "ForeName": "Jan", "Initials": "J"}, {"Identifier": ["0000-0003-0115-4725"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Seoul 08826, Korea. marcdiederich@snu.ac.kr."}], "LastName": "Diederich", "ForeName": "Marc", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Seoul 08826, Korea. jsw0525@snu.ac.kr."}], "LastName": "Ji", "ForeName": "Seungwon", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove, Charles University, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic. violetta.kozik@us.edu.pl."}], "LastName": "Zitko", "ForeName": "Jan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Postepu 36A, 05-552 Jastrzebiec, Poland. ksieron@sum.edu.pl."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria. ksieron@sum.edu.pl."}], "LastName": "Wang", "ForeName": "Dongdong", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia. danica@pharmacy.bg.ac.rs."}], "LastName": "Agbaba", "ForeName": "Danica", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia. knikolic@pharmacy.bg.ac.rs."}], "LastName": "Nikolic", "ForeName": "Katarina", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia. sfilipic@pharmacy.bg.ac.rs."}], "LastName": "Oljacic", "ForeName": "Slavica", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia. molsen@midwestern.edu."}], "LastName": "Vucicevic", "ForeName": "Jelica", "Initials": "J"}, {"Identifier": ["0000-0001-8012-4625"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pharmacological Neuroendocrinology, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 84505 Bratislava, Slovakia. norbert.haider@univie.ac.at."}], "LastName": "Jezova", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": ["0000-0003-3351-1192"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece. jan.vanco@upol.cz."}], "LastName": "Tsantili-Kakoulidou", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0003-0104-9925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Inorganic and Analytical Chemistry, School of Chemical Engineering, National Technical University of Athens, Iroon Polytechniou 9, 15780 Athens, Greece. jan.zitko@faf.cuni.cz."}], "LastName": "Tsopelas", "ForeName": "Fotios", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Nutrition, School of Environment, University of the Aegean, 81400 Myrina, Lemnos, Greece. daniela.jezova@savba.sk."}], "LastName": "Giaginis", "ForeName": "Constantinos", "Initials": "C"}, {"Identifier": ["0000-0002-1001-1243"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. tsantili@pharm.uoa.gr."}], "LastName": "Kowalska", "ForeName": "Teresa", "Initials": "T"}, {"Identifier": ["0000-0001-6917-2028"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. ftsop@central.ntua.gr."}], "LastName": "Sajewicz", "ForeName": "Mieczyslaw", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Neurobiology, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30059 Krakow, Poland. jerzy.silberring@agh.edu.pl."}], "LastName": "Silberring", "ForeName": "Jerzy", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Neurobiology, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30059 Krakow, Poland. przemyslaw.mielczarek@agh.edu.pl."}], "LastName": "Mielczarek", "ForeName": "Przemyslaw", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Neurobiology, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30059 Krakow, Poland. cgiaginis@aegean.gr."}], "LastName": "Smoluch", "ForeName": "Marek", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Crystallography, Faculty of Mathematics, Physics and Chemistry, University of Silesia, Bankowa 12, 40006 Katowice, Poland. izabela.jendrzejewska@us.edu.pl."}], "LastName": "Jendrzejewska", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland. polanski@us.edu.pl."}], "LastName": "Polanski", "ForeName": "Jaroslaw", "Initials": "J"}, {"Identifier": ["0000-0003-2003-9052"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. josef.jampilek@gmail.com."}], "LastName": "Jampilek", "ForeName": "Josef", "Initials": "J"}], "PublicationTypeList": ["Congress"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chemistry, Pharmaceutical"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Intersectoral Collaboration"}, {"QualifierName": [], "DescriptorName": "Pharmacists"}, {"QualifierName": [], "DescriptorName": "Quantitative Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Research Personnel"}, {"QualifierName": [], "DescriptorName": "Slovakia"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "The 46th EuroCongress on Drug Synthesis and Analysis (ECDSA-2017)  [(accessed on 14 September 2017)]; Available online:  https://sites.google.com/site/cfph2017."}, {"Citation": "Faculty of Pharmacy, Comenius University in Bratislava: History of the Faculty.  [(accessed on 14 September 2017)]; Available online:  http://www.fpharm.uniba.sk/en/about-the-faculty/historia."}, {"Citation": "Hann M.M., Keseru G.M. Finding the sweet spot: The role of nature and nurture in medicinal chemistry. Nat. Rev. Drug Discov. 2012;11:355\u2013365. doi: 10.1038/nrd3701.", "ArticleIdList": ["10.1038/nrd3701", "22543468"]}, {"Citation": "Van de Waterbeemd H., Gifford E. ADMET in-silico modeling: Towards prediction paradise? Nat. Rev. Drug Discov. 2003;2:192\u2013204. doi: 10.1038/nrd1032.", "ArticleIdList": ["10.1038/nrd1032", "12612645"]}, {"Citation": "Bak A., Magdziarz T., Polanski J. Pharmacophore-based database mining for probing fragmental drug-likeness of diketo acid analogues. SAR QSAR Environ. Res. 2012;23:185\u2013204. doi: 10.1080/1062936X.2011.645875.", "ArticleIdList": ["10.1080/1062936X.2011.645875", "22292781"]}, {"Citation": "Stanton D.T. QSAR and QSPR model interpretation using partial least squares (PLS) analysis. Curr. Comput. Aided Drug Des. 2012;8:107\u2013127. doi: 10.2174/157340912800492357.", "ArticleIdList": ["10.2174/157340912800492357", "22497466"]}, {"Citation": "Polanski J., Bak A., Gieleciak R., Magdziarz T. Modeling robust QSAR. J. Chem. Inf. Model. 2006;46:2310\u20132318. doi: 10.1021/ci050314b.", "ArticleIdList": ["10.1021/ci050314b", "17125174"]}, {"Citation": "Bak A., Polanski J. The 4D-QSAR study on anti-HIV HEPT analogues. Bioorg. Med. Chem. 2006;14:273\u2013279. doi: 10.1016/j.bmc.2005.08.023.", "ArticleIdList": ["10.1016/j.bmc.2005.08.023", "16185881"]}, {"Citation": "Bak A., Polanski J. Modeling robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: Application to steroid, azo dye, and benzoic acid series. J. Chem. Inf. Model. 2007;47:1469\u20131480. doi: 10.1021/ci700025m.", "ArticleIdList": ["10.1021/ci700025m", "17567123"]}, {"Citation": "Bak A., Kozik V., Smolinski A., Jampilek J. Multidimensional (3D/4D-QSAR) probability-guided pharmacophore mapping: Investigation of activity profile for a series of drug absorption promoters. RSC Adv. 2016;6:76183\u201376205. doi: 10.1039/C6RA15820J.", "ArticleIdList": ["10.1039/C6RA15820J"]}, {"Citation": "Bak A., Wyszomirski M., Magdziarz T., Smolinski A., Polanski J. Structure-based modeling of dye-fiber affinity with SOM paradigm: Application to set of antraquinone derivatives. Comb. Chem. High Throughput Screen. 2014;17:485\u2013502. doi: 10.2174/1386207317666140205195252.", "ArticleIdList": ["10.2174/1386207317666140205195252", "24499310"]}, {"Citation": "Bak A., Daszykowski M., Kaminski Z., Kiec-Kononowicz K., Kuder K., Fraczyk J., Kolesinska B., Ciosek P., Polanski J. Probing an artificial polypeptide receptor library using a series of novel histamin\u0119 H3 receptor ligands. Comb. Chem. High Throughput Screen. 2014;17:146\u2013156. doi: 10.2174/13862073113169990054.", "ArticleIdList": ["10.2174/13862073113169990054", "23859233"]}, {"Citation": "Bak A., Kozik V., Smolinski A., Jampilek J. In-silico estimation of basic-activity relevant parameters for a set of drug absorption promoters. SAR QSAR Environ. Res. 2017;6:427\u2013449. doi: 10.1080/1062936X.2017.1327459.", "ArticleIdList": ["10.1080/1062936X.2017.1327459", "28573881"]}, {"Citation": "Kubinyi H. Hansch Analysis and Related Approaches. Wiley-VCH Verlag GmbH; Weinheim, Germany: 1993."}, {"Citation": "Loenarz C., Schofield C.J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 2011;36:7\u201318. doi: 10.1016/j.tibs.2010.07.002.", "ArticleIdList": ["10.1016/j.tibs.2010.07.002", "20728359"]}, {"Citation": "Lavaissiere L., Jia S., Nishiyama M., de la Monte S., Stern A.M., Wands J.R., Friedman P.A. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J. Clin. Investig. 1996;98:1313\u20131323. doi: 10.1172/JCI118918.", "ArticleIdList": ["10.1172/JCI118918", "PMC507557", "8823296"]}, {"Citation": "Aihara A., Huang C.K., Olsen M.J., Lin Q., Chung W., Tang Q., Dong X., Wands J.R. A cell-surface beta-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Hepatology. 2014;60:1302\u20131313. doi: 10.1002/hep.27275.", "ArticleIdList": ["10.1002/hep.27275", "PMC4176525", "24954865"]}, {"Citation": "Jang M.S., Zlobin A., Kast W.M., Miele L. Notch signalling as a target in multimodality cancer therapy. Curr. Opin. Mol. Ther. 2000;2:55\u201365.", "ArticleIdList": ["11249652"]}, {"Citation": "Iwagami Y., Huang C.K., Olsen M.J., Thomas J.M., Jang G., Kim M., Lin Q., Carlson R.I., Wagner C.E., Dong X., et al. Aspartate beta-hydroxylase modulates cellular senescence through glycogen synthase kinase 3beta in hepatocellular carcinoma. Hepatology. 2016;63:1213\u20131226. doi: 10.1002/hep.28411.", "ArticleIdList": ["10.1002/hep.28411", "PMC4805474", "26683595"]}, {"Citation": "Kumar R., Juillerat-Jeanneret L., Golshayan D. Notch antagonists: Potential modulators of cancer and inflammatory diseases. J. Med. Chem. 2016;59:7719\u20137737. doi: 10.1021/acs.jmedchem.5b01516.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01516", "27045975"]}, {"Citation": "Takebe N., Nguyen D., Yang S.X. Targeting notch signalling pathway in cancer: Clinical development advances and challenges. Pharmacol. Ther. 2014;141:140\u2013149. doi: 10.1016/j.pharmthera.2013.09.005.", "ArticleIdList": ["10.1016/j.pharmthera.2013.09.005", "PMC3982918", "24076266"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Altmann K.H., Gertsch J. Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents. Nat. Prod. Rep. 2007;24:327\u2013357. doi: 10.1039/B515619J.", "ArticleIdList": ["10.1039/B515619J", "17390000"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Kris M.G., O\u2019Connell J.P., Gralla R.J., Wertheim M.S., Parente R.M., Schiff P.B., Young C.W. Phase I trial of taxol given as a 3-hour infusion every 21 days. Cancer Treat. Rep. 1986;70:605\u2013607. doi: 10.1016/0378-8741(86)90014-0.", "ArticleIdList": ["10.1016/0378-8741(86)90014-0", "2871928"]}, {"Citation": "Van Bockxmeer F.M., Martin C.E., Thompson D.E., Constable I.J. Taxol for the treatment of proliferative vitreoretinopathy. Investig. Ophthalmol. Vis. Sci. 1985;26:1140\u20131147.", "ArticleIdList": ["2862129"]}, {"Citation": "Tabaczar S., Koceva-Chyla A., Matczak K., Gwozdzinski K. Molecular mechanisms of antitumour activity of taxanes. I. Interaction of docetaxel with microtubules. Postepy Hig. Med. Dosw. 2010;64:568\u2013681.", "ArticleIdList": ["21109709"]}, {"Citation": "Wang B.C., Yang J.J., Luo D.L., Qiao H.X., Xie Z., Zhang X.C., Wu Y.L. Complete remission and fatal interstitial pneumonitis related to nab-paclitaxel in refractory small cell lung cancer: A case report and review of the literature. Thorac. Cancer. 2012;3:84\u201387. doi: 10.1111/j.1759-7714.2011.00086.x.", "ArticleIdList": ["10.1111/j.1759-7714.2011.00086.x", "28920260"]}, {"Citation": "Wieczorek A., Blauz A., Zal A., Arabshahi H.J., Reynisson J., Hartinger C.G., Rychlik B., Plazuk D. Ferrocenyl paclitaxel and docetaxel derivatives: Impact of an organometallic moiety on the mode of action of Taxanes. Chem. Eur. J. 2016;22:11413\u201311421. doi: 10.1002/chem.201601809.", "ArticleIdList": ["10.1002/chem.201601809", "27376707"]}, {"Citation": "Zhang S.H., Liu G.F., Li X.F., Liu L., Yu S.N. Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: A network meta-analysis. J. Cell. Physiol. 2017 doi: 10.1002/jcp.26183. in press.", "ArticleIdList": ["10.1002/jcp.26183", "28926090"]}, {"Citation": "De Caen A.R., Berg M.D., Chameides L., Gooden C.K., Hickey R.W., Scott H.F., Sutton R.M., Tijssen J.A., Topjian A., van der Jagt E.W., et al. Part 12: Pediatric advanced life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S526\u2013S542. doi: 10.1161/CIR.0000000000000266.", "ArticleIdList": ["10.1161/CIR.0000000000000266", "PMC6191296", "26473000"]}, {"Citation": "Ottaggio L., Bestoso F., Armirotti A., Balbi A., Damonte G., Mazzei M., Sancandi M., Miele M. Taxanes from shells and leaves of Corylus avellana. J. Nat. Prod. 2008;71:58\u201360. doi: 10.1021/np0704046.", "ArticleIdList": ["10.1021/np0704046", "18163585"]}, {"Citation": "Chen Y.R., Li P.C., Yang S., Tong N.N., Zhang J., Zhao X.Y. Tetrandrine enhances the anticancer effects of arsenic trioxide in vitro. Int. J. Clin. Pharmacol. Ther. 2014;52:416\u2013424. doi: 10.5414/CP201939.", "ArticleIdList": ["10.5414/CP201939", "24548979"]}, {"Citation": "Shen Y.C., Chou C.J., Chiou W.F., Chen C.F. Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: Comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol. Pharmacol. 2001;60:1083\u20131090.", "ArticleIdList": ["11641437"]}, {"Citation": "Yang Z., Concannon J., Ng K.S., Seyb K., Mortensen L.J., Ranganath S., Gu F., Levy O., Tong Z., Martyn K., et al. Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation. Sci. Rep. 2016;6:30263. doi: 10.1038/srep30263.", "ArticleIdList": ["10.1038/srep30263", "PMC4960598", "27457881"]}, {"Citation": "Zhang L.J., Geng Y.L., Duan W.J., Wang D.J., Fu M.R., Wang X. Ionic liquid-based ultrasound-assisted extraction of fangchinoline and tetrandrine from Stephaniae tetrandrae. J. Sep. Sci. 2009;32:3550\u20133554. doi: 10.1002/jssc.200900413.", "ArticleIdList": ["10.1002/jssc.200900413", "19764054"]}, {"Citation": "Wang N., Pan W.D., Zhu M.F., Zhang M.S., Hao X.J., Liang G.Y., Feng Y.B. Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br. J. Pharmacol. 2011;164:731\u2013742. doi: 10.1111/j.1476-5381.2011.01349.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01349.x", "PMC3188903", "21418191"]}, {"Citation": "Ma Z.Z., Hano Y., Nomura T., Chen Y.J. Two new pyrroloquinazolinoquinoline alkaloids from Peganum nigellastrum. Heterocycles. 1997;46:541\u2013546."}, {"Citation": "Du W. Towards new anticancer drugs: A decade of advances in synthesis of camptothecins and related alkaloids. Tetrahedron. 2003;59:8649\u20138687. doi: 10.1016/S0040-4020(03)01203-1.", "ArticleIdList": ["10.1016/S0040-4020(03)01203-1"]}, {"Citation": "Pizzolato J.F., Saltz L.B. The camptothecins. Lancet. 2003;361:2235\u20132242. doi: 10.1016/S0140-6736(03)13780-4.", "ArticleIdList": ["10.1016/S0140-6736(03)13780-4", "12842380"]}, {"Citation": "Liang J.L., Cha H.C., Jahng Y. Recent advances in the studies on luotonins. Molecules. 2011;16:4861\u20134883. doi: 10.3390/molecules16064861.", "ArticleIdList": ["10.3390/molecules16064861", "PMC6264391", "21677601"]}, {"Citation": "Haider N., Nu\u00df S. Weinreb amidation as the cornerstone of an improved synthetic route to A-ring-modified derivatives of luotonin A. Molecules. 2012;17:11363\u201311378. doi: 10.3390/molecules171011363.", "ArticleIdList": ["10.3390/molecules171011363", "PMC6268516", "23011278"]}, {"Citation": "Haider N., Meng G.N., Roger S., Wank S. An efficient and selective access to 1-substituted and 3-substituted derivatives of luotonin A. Tetrahedron. 2013;69:7066\u20137072. doi: 10.1016/j.tet.2013.06.040.", "ArticleIdList": ["10.1016/j.tet.2013.06.040"]}, {"Citation": "Zhou H.B., Liu G.S., Yao Z.J. Short and efficient total synthesis of luotonin A and 22-hydroxyacuminatine using a common cascade strategy. J. Org. Chem. 2007;72:6270\u20136272. doi: 10.1021/jo070837d.", "ArticleIdList": ["10.1021/jo070837d", "17608538"]}, {"Citation": "Atia M., Bogdan D., Brugger M., Haider N., Matyus P. Remarkable regioselectivities in the course of the synthesis of two new luotonin A derivatives. Tetrahedron. 2017;73:3231\u20133239. doi: 10.1016/j.tet.2017.04.052.", "ArticleIdList": ["10.1016/j.tet.2017.04.052"]}, {"Citation": "Ibric A., Dutter K., Marian B., Haider N. A facile oxidative opening of the C-ring in luotonin A and derivatives. Molecules. 2017;22:1540. doi: 10.3390/molecules22091540.", "ArticleIdList": ["10.3390/molecules22091540", "PMC6151605", "28895937"]}, {"Citation": "Kruse J.P., Gu W. Modes of p53 regulation. Cell. 2009;137:609\u2013622. doi: 10.1016/j.cell.2009.04.050.", "ArticleIdList": ["10.1016/j.cell.2009.04.050", "PMC3737742", "19450511"]}, {"Citation": "Vaseva A.V., Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta. 2009;1787:414\u2013420. doi: 10.1016/j.bbabio.2008.10.005.", "ArticleIdList": ["10.1016/j.bbabio.2008.10.005", "PMC2819081", "19007744"]}, {"Citation": "Haupt S. Apoptosis\u2014The p53 network. J. Cell Sci. 2003;116:4077\u20134085. doi: 10.1242/jcs.00739.", "ArticleIdList": ["10.1242/jcs.00739", "12972501"]}, {"Citation": "Muller P.A.J., Vousden K.H. P53 Mutations in cancer. Nat. Cell Biol. 2013;15:2\u20138. doi: 10.1038/ncb2641.", "ArticleIdList": ["10.1038/ncb2641", "23263379"]}, {"Citation": "Olivier M., Hollstein M., Hainaut P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2010;2:a001008. doi: 10.1101/cshperspect.a001008.", "ArticleIdList": ["10.1101/cshperspect.a001008", "PMC2827900", "20182602"]}, {"Citation": "Koonin E.V., Rogozin I.B., Glazko G.V. p53 Gain-of-Function. Cell Cycle. 2005;4:686\u2013688. doi: 10.4161/cc.4.5.1691.", "ArticleIdList": ["10.4161/cc.4.5.1691", "15846083"]}, {"Citation": "Duffy M.J., Synnott N.C., McGowan P.M., Crown J., O\u2019Connor D., Gallagher W.M. P53 as a target for the treatment of cancer. Cancer Treat. Rev. 2014;40:1153\u20131160. doi: 10.1016/j.ctrv.2014.10.004.", "ArticleIdList": ["10.1016/j.ctrv.2014.10.004", "25455730"]}, {"Citation": "Khoo K.H., Hoe K.K., Verma C.S., Lane D.P. Drugging the p53 pathway: Understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 2014;13:217\u2013236. doi: 10.1038/nrd4288.", "ArticleIdList": ["10.1038/nrd4288", "24577402"]}, {"Citation": "Takimoto R., Wang W., Dicker D.T., Rastinejad F., Lyssikatos J., el-Deiry W.S. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein. Cancer Biol. Ther. 2002;1:47\u201355. doi: 10.4161/cbt.1.1.41.", "ArticleIdList": ["10.4161/cbt.1.1.41", "12174820"]}, {"Citation": "Xu J., Timares L., Heilpern C., Weng Z., Li C., Xu H., Pressey J.G., Elmets C., Kopelovich L., Athar M. Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis. Cancer Res. 2010;70:6566\u20136576. doi: 10.1158/0008-5472.CAN-10-0942.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-0942", "PMC2922473", "20682800"]}, {"Citation": "Musiol R., Jampilek J., Buchta V., Silva L., Niedbala H., Podeszwa B., Palka A., Majerz-Maniecka K., Oleksyn B., Polanski J. Antifungal properties of new series of quinoline derivatives. Bioorg. Med. Chem. 2006;14:3592\u20133598. doi: 10.1016/j.bmc.2006.01.016.", "ArticleIdList": ["10.1016/j.bmc.2006.01.016", "16458522"]}, {"Citation": "Cieslik W., Musiol R., Nycz J.E., Jampilek J., Vejsova M., Wolff M., Machura B., Polanski J. Contribution to investigation of antimicrobial activity of styrylquinolines. Bioorg. Med. Chem. 2012;20:6960\u20136968. doi: 10.1016/j.bmc.2012.10.027.", "ArticleIdList": ["10.1016/j.bmc.2012.10.027", "23159041"]}, {"Citation": "Musiol R., Tabak D., Niedbala H., Podeszwa B., Jampilek J., Kralova K., Dohnal J., Finster J., Mencel A., Polanski J. Investigating biological activity spectrum for novel quinoline analogues 2: Hydroxyquinolinecarboxamides with photosynthesis-inhibiting activity. Bioorg. Med. Chem. 2008;16:4490\u20134499. doi: 10.1016/j.bmc.2008.02.065.", "ArticleIdList": ["10.1016/j.bmc.2008.02.065", "18342517"]}, {"Citation": "Musiol R., Jampilek J., Nycz J.E., Pesko M., Carroll J., Kralova K., Vejsova M., O\u2019Mahony J., Coffey A., Mrozek A., et al. Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines. Molecules. 2010;15:288\u2013304. doi: 10.3390/molecules15010288.", "ArticleIdList": ["10.3390/molecules15010288", "PMC6256987", "20110891"]}, {"Citation": "Jampilek J., Musiol R., Pesko M., Kralova K., Vejsova M., Carroll J., Coffey A., Finster J., Tabak D., Niedbala H., et al. Ring-substituted 4-hydroxy-1H-quinolin-2-ones: Preparation and biological activity. Molecules. 2009;14:1145\u20131159. doi: 10.3390/molecules14031145.", "ArticleIdList": ["10.3390/molecules14031145", "PMC6253998", "19305366"]}, {"Citation": "Cieslik W., Spaczynska E., Malarz K., Tabak D., Nevin E., O\u2019Mahony J., Coffey A., Mrozek-Wilczkiewicz A., Jampilek J., Musiol R. Investigation of the antimycobacterial activity of 8-hydroxyquinolines. Med. Chem. 2015;11:771\u2013779. doi: 10.2174/1573406410666150807111703.", "ArticleIdList": ["10.2174/1573406410666150807111703", "26256587"]}, {"Citation": "Polanski J., Niedbala H., Musiol R., Podeszwa B., Tabak D., Palka A., Mencel A., Mouscadet J.F., Le Bret M. Fragment based approach for the investigation of HIV-1 integrase inhibition. Lett. Drug Des. Discov. 2007;4:99\u2013105. doi: 10.2174/157018007779422532.", "ArticleIdList": ["10.2174/157018007779422532"]}, {"Citation": "Polanski J., Niedbala H., Musiol R., Podeszwa B., Tabak D., Palka A., Mencel A., Finster J., Mouscadet J.F., Bret M.L. 5-Hydroxy-6-quinaldic acid as a novel molecular scaffold for HIV-1 integrase inhibitors. Lett. Drug Des. Discov. 2006;3:175\u2013178. doi: 10.2174/157018006776286934.", "ArticleIdList": ["10.2174/157018006776286934"]}, {"Citation": "Kurczyk A., Warszycki D., Musiol R., Kafel R., Bojarski A.J., Polanski J. Ligand-based virtual screening in a search for novel anti-HIV-1 chemotypes. J. Chem. Inf. Model. 2015;55:2168\u20132177. doi: 10.1021/acs.jcim.5b00295.", "ArticleIdList": ["10.1021/acs.jcim.5b00295", "26431196"]}, {"Citation": "Podeszwa B., Niedbala H., Polanski J., Musiol R., Tabak D., Finster J., Serafin K., Milczarek M., Wietrzyk J., Boryczka S., et al. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumour cell lines. Bioorg. Med. Chem. Lett. 2007;17:6138\u20136141. doi: 10.1016/j.bmcl.2007.09.040.", "ArticleIdList": ["10.1016/j.bmcl.2007.09.040", "17904844"]}, {"Citation": "Serda M., Kalinowski D.S., Mrozek-Wilczkiewicz A., Musiol R., Szurko A., Ratuszna A., Pantarat N., Kovacevic Z., Merlot A.M., Richardson D.R., et al. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumour efficacy. Bioorg. Med. Chem. Lett. 2012;22:5527\u20135531. doi: 10.1016/j.bmcl.2012.07.030.", "ArticleIdList": ["10.1016/j.bmcl.2012.07.030", "22858101"]}, {"Citation": "Serda M., Kalinowski D.S., Rasko N., Potuckova E., Mrozek-Wilczkiewicz A., Musiol R., Malecki J.G., Sajewicz M., Ratuszna A., Muchowicz A., et al. Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: Dissection of critical structure-activity relationships. PLoS ONE. 2014;9:e110291. doi: 10.1371/journal.pone.0110291.", "ArticleIdList": ["10.1371/journal.pone.0110291", "PMC4199632", "25329549"]}, {"Citation": "Mrozek-Wilczkiewicz A., Serda M., Musiol R., Malecki G., Szurko A., Muchowicz A., Golab J., Ratuszna A., Polanski J. Iron chelators in photodynamic therapy revisited: Synergistic effect by novel highly active thiosemicarbazones. ACS Med. Chem. Lett. 2014;5:336\u2013339. doi: 10.1021/ml400422a.", "ArticleIdList": ["10.1021/ml400422a", "PMC4027794", "24900837"]}, {"Citation": "Pastuch-Gawolek G., Malarz K., Mrozek-Wilczkiewicz A., Musiol M., Serda M., Czaplinska B., Musiol R. Small molecule glycoconjugates with anticancer activity. Eur. J. Med. Chem. 2016;112:130\u2013144. doi: 10.1016/j.ejmech.2016.01.061.", "ArticleIdList": ["10.1016/j.ejmech.2016.01.061", "26890119"]}, {"Citation": "Mrozek-Wilczkiewicz A., Malarz K., Rams-Baron M., Serda M., Bauer D., Montforts F.P., Ratuszna A., Burley T., Polanski J., Musiol R. Iron chelators and exogenic photosensitizers. Synergy through oxidative stress gene expression. J. Cancer. 2017;8:1979\u20131987. doi: 10.7150/jca.17959.", "ArticleIdList": ["10.7150/jca.17959", "PMC5559958", "28819397"]}, {"Citation": "Mrozek-Wilczkiewicz A., Kalinowski D.S., Musiol R., Finster J., Szurko A., Serafin K., Knas M., Kamalapuram S.K., Kovacevic Z., Jampilek J., Ratuszna A., et al. Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones. Bioorg. Med. Chem. 2010;18:2664\u20132671. doi: 10.1016/j.bmc.2010.02.025.", "ArticleIdList": ["10.1016/j.bmc.2010.02.025", "20303768"]}, {"Citation": "Mrozek-Wilczkiewicz A., Spaczynska E., Malarz K., Cieslik W., Rams-Baron M., Krystof V., Musiol R. Design, synthesis and in vitro activity of anticancer styrylquinolines. The p53 independent mechanism of action. PLoS ONE. 2015;10:e0142678. doi: 10.1371/journal.pone.0142678.", "ArticleIdList": ["10.1371/journal.pone.0142678", "PMC4657899", "26599982"]}, {"Citation": "Barry N.P.E., Sadler P.J. Exploration of the medical periodic table: Towards new targets. Chem. Commun. 2013;49:5106\u20135131. doi: 10.1039/c3cc41143e.", "ArticleIdList": ["10.1039/c3cc41143e", "23636600"]}, {"Citation": "Azuara L.R. Copper Amino Acidate Diimine Nitrate Compounds and Their Methyl Derivatives and a Process for Preparing Them. 5,576,326. US Patent. 1996 Nov 19;"}, {"Citation": "Serment-Guerrero J., Bravo-Gomez M.E., Lara-Rivera E., Ruiz-Azuara L. Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action. J. Inorg. Biochem. 2017;166:68\u201375. doi: 10.1016/j.jinorgbio.2016.11.007.", "ArticleIdList": ["10.1016/j.jinorgbio.2016.11.007", "27838580"]}, {"Citation": "Krikavova R., Vanco J., Travnicek Z., Hutyra J., Dvorak Z. Design and characterization of highly in vitro antitumour active ternary copper(II) complexes containing 2\u2032-hydroxychalcone ligands. J. Inorg. Biochem. 2016;163:8\u201317. doi: 10.1016/j.jinorgbio.2016.07.005.", "ArticleIdList": ["10.1016/j.jinorgbio.2016.07.005", "27423037"]}, {"Citation": "Krikavova R., Vanco J., Travnicek Z., Bucht\u00edk R., Dvorak Z. Copper(II) quinolinonato-7-carboxamido complexes as potent antitumour agents with broad spectra and selective effects. RSC Adv. 2016;6:3899\u20133909. doi: 10.1039/C5RA22141B.", "ArticleIdList": ["10.1039/C5RA22141B"]}, {"Citation": "Travnicek Z., Vanco J., Bucht\u00edk R., Dvorak Z. Utilization of Copper Complexes Involving 2-Phenyl-3-Hydroxy-4(1H)-Quinolinone and 1,10-Phenanthroline Derivatives for the Preparation of Drugs for the Treatment of Tumour Diseases. EP2650000 B1. EU Patent. 2017 Mar 15;"}, {"Citation": "Travnicek Z., Vanco J., Hutyra J., Krikavova R., Dvorak Z. Complexes of Copper with Derivatives (E)-1-(2\u2032-Hydroxyphenyl)-3-phenyl-prop-2-en-1-one and Their Use as Pharmaceuticals in the Antitumour Therapy. Application PV-2015-598. Czech Patent. 2015 Sep 2;"}, {"Citation": "Cerella C., Gaigneaux A., Mazumder A., Lee J.Y., Saland E., Radogna F., Farge T., Vergez F., Recher C., Sarry J.E., et al. Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia. Leukemia. 2017;31:755\u2013759. doi: 10.1038/leu.2016.341.", "ArticleIdList": ["10.1038/leu.2016.341", "PMC5339427", "27872497"]}, {"Citation": "Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P. Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 2014;15:135\u2013147. doi: 10.1038/nrm3737.", "ArticleIdList": ["10.1038/nrm3737", "24452471"]}, {"Citation": "Lockshin R.A., Williams C.M. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. J. Insect Physiol. 1965;11:123\u2013133. doi: 10.1016/0022-1910(65)90099-5.", "ArticleIdList": ["10.1016/0022-1910(65)90099-5", "14287218"]}, {"Citation": "Diederich M., Cerella C. Non-canonical programmed cell death mechanisms triggered by natural compounds. Semin. Cancer Biol. 2016;40/41:4\u201334. doi: 10.1016/j.semcancer.2016.06.001.", "ArticleIdList": ["10.1016/j.semcancer.2016.06.001", "27262793"]}, {"Citation": "Pol J., Vacchelli E., Aranda F., Castoldi F., Eggermont A., Cremer I., Sautes-Fridman C., Fucikova J., Galon J., Spisek R., et al. Trial watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 2015;4:e1008866. doi: 10.1080/2162402X.2015.1008866.", "ArticleIdList": ["10.1080/2162402X.2015.1008866", "PMC4485780", "26137404"]}, {"Citation": "World Health Organization  Global Tuberculosis Report 2016.  [(accessed on 2 September 2017)]; WHO/HTM/TB/2016.13. Available online:  http://www.who.int/tb/publications/global_report/en/"}, {"Citation": "Malone L., Schurr A., Lindh H., McKenzie D., Kiser J.S., Williams J.H. The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice. Am. Rev. Tuberc. 1952;65:511\u2013518.", "ArticleIdList": ["14924173"]}, {"Citation": "Zhang Y., Wade M.M., Scorpio A., Zhang H., Sun Z.H. Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 2003;52:790\u2013795. doi: 10.1093/jac/dkg446.", "ArticleIdList": ["10.1093/jac/dkg446", "14563891"]}, {"Citation": "Peterson N.D., Rosen B.C., Dillon N.A., Baughn A.D. Uncoupling environmental pH and intrabacterial acidification from pyrazinamide susceptibility in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2015;59:7320\u20137326. doi: 10.1128/AAC.00967-15.", "ArticleIdList": ["10.1128/AAC.00967-15", "PMC4649215", "26369957"]}, {"Citation": "Zimhony O., Vilcheze C., Arai M., Welch J.T., Jacobs W.R. Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli. Antimicrob. Agents Chemother. 2007;51:752\u2013754. doi: 10.1128/AAC.01369-06.", "ArticleIdList": ["10.1128/AAC.01369-06", "PMC1797748", "17101678"]}, {"Citation": "Boshoff H.I., Mizrahi V., Barry C.E. Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I. J. Bacteriol. 2002;184:2167\u20132172. doi: 10.1128/JB.184.8.2167-2172.2002.", "ArticleIdList": ["10.1128/JB.184.8.2167-2172.2002", "PMC134955", "11914348"]}, {"Citation": "Ngo S.C., Zimhony O., Chung W.J., Sayahi H., Jacobs W.R., Welch J.T. Inhibition of isolated mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs. Antimicrob. Agents Chemother. 2007;51:2430\u20132435. doi: 10.1128/AAC.01458-06.", "ArticleIdList": ["10.1128/AAC.01458-06", "PMC1913273", "17485499"]}, {"Citation": "Zimhony O., Cox J.S., Welch J.T., Vilcheze C., Jacobs W.R. Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Nat. Med. 2000;6:1043\u20131047.", "ArticleIdList": ["10973326"]}, {"Citation": "Sayahi H., Zimhony O., Jacobs W.R., Shekhtman A., Welch J.T. Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I. Bioorg. Med. Chem. Lett. 2011;21:4804\u20134807. doi: 10.1016/j.bmcl.2011.06.055.", "ArticleIdList": ["10.1016/j.bmcl.2011.06.055", "PMC4356482", "21775138"]}, {"Citation": "Sayahi H., Pugliese K.M., Zimhony O., Jacobs W.R., Shekhtman A., Welch J.T. Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I. Chem. Biodivers. 2012;9:2582\u20132596. doi: 10.1002/cbdv.201200291.", "ArticleIdList": ["10.1002/cbdv.201200291", "23161636"]}, {"Citation": "Ciccarelli L., Connell S.R., Enderle M., Mills D.J., Vonck J., Grininger M. Structure and conformational variability of the mycobacterium tuberculosis fatty acid synthase multienzyme complex. Structure. 2013;21:1251\u20131257. doi: 10.1016/j.str.2013.04.023.", "ArticleIdList": ["10.1016/j.str.2013.04.023", "23746808"]}, {"Citation": "Shi W.L., Zhang X.L., Jiang X., Yuan H.M., Lee J.S., Barry C.E., Wang H.H., Zhang W.H., Zhang Y. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science. 2011;333:1630\u20131632. doi: 10.1126/science.1208813.", "ArticleIdList": ["10.1126/science.1208813", "PMC3502614", "21835980"]}, {"Citation": "Yang J.J., Liu Y.D., Bi J., Cai Q.X., Liao X.L., Li W.Q., Guo C.Y., Zhang Q., Lin T.W., Zhao Y.F., et al. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide. Mol. Microbiol. 2015;95:791\u2013803. doi: 10.1111/mmi.12892.", "ArticleIdList": ["10.1111/mmi.12892", "25430994"]}, {"Citation": "Shi W.L., Chen J.Z., Feng J., Cui P., Zhang S., Weng X.H., Zhang W.H., Zhang Y. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. Emerg. Microbes Infect. 2014;3:e58. doi: 10.1038/emi.2014.61.", "ArticleIdList": ["10.1038/emi.2014.61", "PMC4150287", "26038753"]}, {"Citation": "Pandey B., Grover S., Tyagi C., Goyal S., Jamal S., Singh A., Kaur J., Grover A. Molecular principles behind pyrazinamide resistance due to mutations in panD gene in Mycobacterium tuberculosis. Gene. 2016;581:31\u201342. doi: 10.1016/j.gene.2016.01.024.", "ArticleIdList": ["10.1016/j.gene.2016.01.024", "26784657"]}, {"Citation": "Kim H., Shibayama K., Rimbara E., Mori S. Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamide. PLoS ONE. 2014;9:e100062. doi: 10.1371/journal.pone.0100062.", "ArticleIdList": ["10.1371/journal.pone.0100062", "PMC4065032", "24949952"]}, {"Citation": "Servusova B., Paterova P., Mandikova J., Kubicek V., Kucera R., Kunes J., Dolezal M., Zitko J. Alkylamino derivatives of pyrazinamide: Synthesis and antimycobacterial evaluation. Bioorg. Med. Chem. Lett. 2014;24:450\u2013453. doi: 10.1016/j.bmcl.2013.12.054.", "ArticleIdList": ["10.1016/j.bmcl.2013.12.054", "24388809"]}, {"Citation": "Hopkins P.N. Molecular biology of atherosclerosis. Physiol. Rev. 2013;93:1317\u20131542. doi: 10.1152/physrev.00004.2012.", "ArticleIdList": ["10.1152/physrev.00004.2012", "23899566"]}, {"Citation": "Rohatgi A., Khera A., Berry J.D., Givens E.G., Ayers C.R., Wedin K.E., Neeland I.J., Yuhanna I.S., Rader D.R., de Lemos J.A., et al. HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 2014;371:2383\u20132393. doi: 10.1056/NEJMoa1409065.", "ArticleIdList": ["10.1056/NEJMoa1409065", "PMC4308988", "25404125"]}, {"Citation": "Mishra B.B., Tiwari V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011;46:4769\u201347807. doi: 10.1016/j.ejmech.2011.07.057.", "ArticleIdList": ["10.1016/j.ejmech.2011.07.057", "21889825"]}, {"Citation": "Koehn F.E., Carter G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005;4:206\u2013220. doi: 10.1038/nrd1657.", "ArticleIdList": ["10.1038/nrd1657", "15729362"]}, {"Citation": "Waltenberger B., Mocan A., Smejkal K., Heiss E.H., Atanasov A.G. Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules. 2016;21:807. doi: 10.3390/molecules21060807.", "ArticleIdList": ["10.3390/molecules21060807", "PMC4928700", "27338339"]}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L.M., Schwaiger S., Heiss E.H., et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33:1582\u20131614. doi: 10.1016/j.biotechadv.2015.08.001.", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Jiang Z.M., Sang H.Q., Fu X., Liang Y., Li L. Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages. Biotechnol. Appl. Biochem. 2015;62:840\u2013847. doi: 10.1002/bab.1328.", "ArticleIdList": ["10.1002/bab.1328", "25496323"]}, {"Citation": "He X.W., Yu D., Li W.L., Zheng Z., Lv C.L., Li C., Liu P., Xu C.Q., Hu X.F., Jin X.P. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPAR gamma-LXR alpha-ABCA1/ABCG1 pathway. Biomed. Pharmacother. 2016;83:257\u2013264. doi: 10.1016/j.biopha.2016.06.046.", "ArticleIdList": ["10.1016/j.biopha.2016.06.046", "27389392"]}, {"Citation": "Wang S., Zhang X., Liu M.Y., Luan H., Ji Y.B., Guo P., Wu C.M. Chrysin inhibits foam cell formation through promoting cholesterol efflux from RAW264.7 macrophages. Pharm. Biol. 2015;53:1481\u20131487. doi: 10.3109/13880209.2014.986688.", "ArticleIdList": ["10.3109/13880209.2014.986688", "25857322"]}, {"Citation": "Iio A., Ohguchi K., Iinuma M., Nozawa Y., Ito M. Hesperetin upregulates ABCA1 expression and promotes cholesterol efflux from THP-1 macrophages. J. Nat. Prod. 2012;75:563\u2013566. doi: 10.1021/np200696r.", "ArticleIdList": ["10.1021/np200696r", "22429094"]}, {"Citation": "Sun L.Q., Li E., Wang F., Wang T., Qin Z.P., Niu S.H., Qiu C.G. Quercetin increases macrophage cholesterol efflux to inhibit foam cell formation through activating PPAR gamma-ABCA1 pathway. Int. J. Clin. Exp. Pathol. 2015;8:10854\u201310860.", "ArticleIdList": ["PMC4637614", "26617799"]}, {"Citation": "Chang Y.C., Lee T.S., Chiang A.N. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J. Lipid Res. 2012;53:1840\u20131850. doi: 10.1194/jlr.M024471.", "ArticleIdList": ["10.1194/jlr.M024471", "PMC3413225", "22711909"]}, {"Citation": "Wang L.M., Rotter S., Ladurner A., Heiss E.H., Oberlies N.H., Dirsch V.M., Atanasov A.G. Silymarin constituents enhance ABCA1 expression in THP-1 macrophages. Molecules. 2016;21:55. doi: 10.3390/molecules21010055.", "ArticleIdList": ["10.3390/molecules21010055", "PMC4748397", "26729088"]}, {"Citation": "Rosenblat M., Volkova N., Coleman R., Almagor Y., Aviram M. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: Enhanced macrophage cholesterol efflux. J. Nutr. Biochem. 2008;19:514\u2013523. doi: 10.1016/j.jnutbio.2007.06.007.", "ArticleIdList": ["10.1016/j.jnutbio.2007.06.007", "17904345"]}, {"Citation": "Zhao J.F., Jim Leu S.J., Shyue S.K., Su K.H., Wei J., Lee T.S. Novel effect of paeonol on the formation of foam cells: Promotion of LXRalpha-ABCA1-dependent cholesterol efflux in macrophages. Am. J. Chin. Med. 2013;41:1079\u20131096. doi: 10.1142/S0192415X13500730.", "ArticleIdList": ["10.1142/S0192415X13500730", "24117070"]}, {"Citation": "Zhao S.J., Li J.K., Wang L.F., Wu X.X. Pomegranate peel polyphenols inhibit lipid accumulation and enhance cholesterol efflux in raw264.7 macrophages. Food Funct. 2016;7:3201\u20133210. doi: 10.1039/C6FO00347H.", "ArticleIdList": ["10.1039/C6FO00347H", "27334099"]}, {"Citation": "Zhou W.J., Lin J.C., Chen H.E., Wang J.J., Liu Y., Xia M. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Br. J. Nutr. 2015;114:509\u2013518. doi: 10.1017/S0007114515002159.", "ArticleIdList": ["10.1017/S0007114515002159", "26201974"]}, {"Citation": "Bechor S., Zolberg Relevy N., Harari A., Almog T., Kamari Y., Ben-Amotz A., Harats D., Shaish A. 9-cis-beta-Carotene increased cholesterol efflux to HDL in macrophages. Nutrients. 2016;8:435. doi: 10.3390/nu8070435.", "ArticleIdList": ["10.3390/nu8070435", "PMC4963911", "27447665"]}, {"Citation": "Iizuka M., Ayaori M., Uto-Kondo H., Yakushiji E., Takiguchi S., Nakaya K., Hisada T., Sasaki M., Komatsu T., Yogo M., et al. Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages. J. Nutr. Sci. Vitaminol. 2012;58:96\u2013104. doi: 10.3177/jnsv.58.96.", "ArticleIdList": ["10.3177/jnsv.58.96", "22790567"]}, {"Citation": "Kammerer I., Ringseis R., Biemann R., Wen G.P., Eder K. 13-Hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages. Lipids Health Dis. 2011;10:222. doi: 10.1186/1476-511X-10-222.", "ArticleIdList": ["10.1186/1476-511X-10-222", "PMC3248880", "22129452"]}, {"Citation": "Shao F., Ford D.A. Differential regulation of ABCA1 and macrophage cholesterol efflux by elaidic and oleic acids. Lipids. 2013;48:757\u2013767. doi: 10.1007/s11745-013-3808-0.", "ArticleIdList": ["10.1007/s11745-013-3808-0", "PMC3732740", "23800855"]}, {"Citation": "Dong S.Z., Zhao S.P., Wu Z.H., Yang J., Xie X.Z., Yu B.L., Nie S. Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol. Cell. Biochem. 2011;358:281\u2013285. doi: 10.1007/s11010-011-0978-z.", "ArticleIdList": ["10.1007/s11010-011-0978-z", "21748336"]}, {"Citation": "Liu T.R., Li C., Sun H.G., Luo T.T., Tan Y., Tian D., Guo Z.G. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage. Inflamm. Res. 2014;63:841\u2013850. doi: 10.1007/s00011-014-0758-9.", "ArticleIdList": ["10.1007/s00011-014-0758-9", "25064633"]}, {"Citation": "Lin X.L., Liu M.H., Hu H.J., Feng H.R., Fan X.J., Zou W.W., Pan Y.Q., Hu X.M., Wang Z. Curcumin enhanced cholesterol efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXR alpha signalling in THP-1 macrophage-derived foam cells. DNA Cell Biol. 2015;34:561\u2013572. doi: 10.1089/dna.2015.2866.", "ArticleIdList": ["10.1089/dna.2015.2866", "26102194"]}, {"Citation": "Liu X., Kunert O., Blunder M., Fakhrudin N., Noha S.M., Malainer C., Schinkovitz A., Heiss E.H., Atanasov A.G., Kollroser M., et al. Polyyne hybrid compounds from Notopterygium incisum with peroxisome proliferator-activated receptor gamma agonistic effects. J. Nat. Prod. 2014;77:2513\u20132521. doi: 10.1021/np500605v.", "ArticleIdList": ["10.1021/np500605v", "PMC4251066", "25333853"]}, {"Citation": "Atanasov A.G., Blunder M., Fakhrudin N., Liu X., Noha S.M., Malainer C., Kramer M.P., Cocic A., Kunert O., Schinkovitz A., et al. Polyacetylenes from Notopterygium incisum\u2014New selective partial agonists of peroxisome proliferator-activated receptor-gamma. PLoS ONE. 2013;8:e61755. doi: 10.1371/journal.pone.0061755.", "ArticleIdList": ["10.1371/journal.pone.0061755", "PMC3632601", "23630612"]}, {"Citation": "Wang L., Palme V., Schilcher N., Ladurner A., Heiss E.H., Stangl H., Bauer R., Dirsch V.M., Atanasov A.G. The dietary constituent falcarindiol promotes cholesterol efflux from THP-1 macrophages by increasing ABCA1 gene transcription and protein stability. Front. Pharmacol. 2017;8:596. doi: 10.3389/fphar.2017.00596.", "ArticleIdList": ["10.3389/fphar.2017.00596", "PMC5585181", "28919859"]}, {"Citation": "Gao H., Li L.Y., Li L., Gong B., Dong P.Z., Fordjour P.A., Zhu Y., Fan G.W. Danshensu promotes cholesterol efflux in RAW264.7 macrophages. Lipids. 2016;51:1083\u20131092. doi: 10.1007/s11745-016-4178-1.", "ArticleIdList": ["10.1007/s11745-016-4178-1", "27514857"]}, {"Citation": "Lv Y.C., Yang J., Yao F., Xie W., Tang Y.Y., Ouyang X.P., He P.P., Tan Y.L., Li L., Zhang M., et al. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1. Atherosclerosis. 2015;240:80\u201389. doi: 10.1016/j.atherosclerosis.2015.02.044.", "ArticleIdList": ["10.1016/j.atherosclerosis.2015.02.044", "25765596"]}, {"Citation": "Yue J.M., Li B., Jing Q.P., Guan Q.B. Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-gamma and LXR alpha. Biochem. Biophys. Res. Commun. 2015;462:233\u2013238. doi: 10.1016/j.bbrc.2015.04.122.", "ArticleIdList": ["10.1016/j.bbrc.2015.04.122", "25956064"]}, {"Citation": "Xu X.L., Li Q., Pang L.W., Huang G.Q., Huang J.C., Shi M., Sun X.T., Wang Y.Q. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-gamma/LXR-alpha signalling pathway. Biochem. Biophys. Res. Commun. 2013;441:321\u2013326. doi: 10.1016/j.bbrc.2013.10.050.", "ArticleIdList": ["10.1016/j.bbrc.2013.10.050", "24140409"]}, {"Citation": "Uto-Kondo H., Ayaori M., Nakaya K., Takiguchi S., Yakushiji E., Ogura M., Terao Y., Ozasa H., Sasaki M., Komatsu T., et al. Citrulline increases cholesterol efflux from macrophages in vitro and ex vivo via ATP-binding cassette transporters. J. Clin. Biochem. Nutr. 2014;55:32\u201339. doi: 10.3164/jcbn.13-76.", "ArticleIdList": ["10.3164/jcbn.13-76", "PMC4078065", "25120277"]}, {"Citation": "Fu X., Xu A.G., Yao M.Y., Guo L., Zhao L.S. Emodin enhances cholesterol efflux by activating peroxisome proliferator-activated receptor-gamma in oxidized low density lipoprotein-loaded THP1 macrophages. Clin. Exp. Pharmacol. Physiol. 2014;41:679\u2013684.", "ArticleIdList": ["24837536"]}, {"Citation": "Wang L.M., Wesemann S., Krenn L., Ladurner A., Heiss E.H., Dirsch V.M., Atanasov A.G. Erythrodiol, an olive oil constituent, increases the half-life of ABCA1 and enhances cholesterol efflux from THP-1-derived macrophages. Front. Pharmacol. 2017;8:375. doi: 10.3389/fphar.2017.00375.", "ArticleIdList": ["10.3389/fphar.2017.00375", "PMC5468437", "28659806"]}, {"Citation": "Wang L., Ladurner A., Latkolik S., Schwaiger S., Linder T., Hosek J., Palme V., Schilcher N., Polansky O., Heiss E.H., et al. Leoligin, the major lignan from edelweiss (Leontopodium nivale subsp. alpinum), promotes cholesterol efflux from THP-1 macrophages. J. Nat. Prod. 2016;79:1651\u20131657.", "ArticleIdList": ["PMC4924082", "27220065"]}, {"Citation": "Wang L., Palme V., Rotter S., Schilcher N., Cukaj M., Wang D., Ladurner A., Heiss E.H., Stangl H., Dirsch V.M., et al. Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages. Mol. Nutr. Food Res. 2017;61:1500960. doi: 10.1002/mnfr.201500960.", "ArticleIdList": ["10.1002/mnfr.201500960", "PMC5382977", "27862930"]}, {"Citation": "Li C.H., Gong D., Chen L.Y., Zhang M., Xia X.D., Cheng H.P., Huang C., Zhao Z.W., Zheng X.L., Tang X.E., et al. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. Eur. J. Pharmacol. 2017;811:74\u201386. doi: 10.1016/j.ejphar.2017.05.055.", "ArticleIdList": ["10.1016/j.ejphar.2017.05.055", "28576406"]}, {"Citation": "Wu C.M., Chen R., Liu M.Y., Liu D., Li X., Wang S., Niu S.W., Guo P., Lin W.H. Spiromastixones inhibit foam cell formation via regulation of cholesterol efflux and uptake in RAW264.7 macrophages. Mar. Drugs. 2015;13:6352\u20136365. doi: 10.3390/md13106352.", "ArticleIdList": ["10.3390/md13106352", "PMC4626694", "26473890"]}, {"Citation": "Yin K., You Y., Swier V., Tang L., Radwan M.M., Pandya A.N., Agrawal D.K. Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine. Arterioscler. Thromb. Vasc. Biol. 2015;35:2432\u20132442. doi: 10.1161/ATVBAHA.115.306132.", "ArticleIdList": ["10.1161/ATVBAHA.115.306132", "PMC4618721", "26381871"]}, {"Citation": "Majdalawieh A.F., Ro H.S. Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPAR gamma 1 and LXR alpha transcriptional activity in a MAPK-dependent manner. Eur. J. Nutr. 2015;54:691\u2013700. doi: 10.1007/s00394-014-0747-3.", "ArticleIdList": ["10.1007/s00394-014-0747-3", "25081501"]}, {"Citation": "Liu N., Wu C.M., Sun L.Z., Zheng J., Guo P. Sesamin enhances cholesterol efflux in RAW264.7 macrophages. Molecules. 2014;19:7516\u20137527. doi: 10.3390/molecules19067516.", "ArticleIdList": ["10.3390/molecules19067516", "PMC6271023", "24914897"]}, {"Citation": "Majdalawieh A.F., Ro H.S. The anti-atherogenic properties of sesamin are mediated via improved macrophage cholesterol efflux through PPAR gamma 1-LXR alpha and MAPK signalling. Int. J. Vitam. Nutr. Res. 2014;84:79\u201391. doi: 10.1024/0300-9831/a000195.", "ArticleIdList": ["10.1024/0300-9831/a000195", "25835238"]}, {"Citation": "Wang H., Liu Y., Zhu L., Wang W.J., Wan Z.F., Chen F.Y., Wu Y., Zhou J., Yuan Z.Y. 17-beta-Estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor alpha-dependent pathway. Int. J. Mol. Med. 2014;33:550\u2013558.", "ArticleIdList": ["24398697"]}, {"Citation": "Wang D.D., Tosevska A., Heiss E.H., Ladurner A., Molzer C., Wallner M., Bulmer A., Wagner K.H., Dirsch V.M., Atanasov A.G. Bilirubin decreases macrophage cholesterol efflux and ATP-binding cassette transporter A1 protein expression. J. Am. Heart Assoc. 2017;6:e005520. doi: 10.1161/JAHA.117.005520.", "ArticleIdList": ["10.1161/JAHA.117.005520", "PMC5524097", "28455345"]}, {"Citation": "Zhang H.M., Li X.Y., Qian Z.J. Regulation of macrophage cholesterol efflux and liver X receptor a activation by nicotine. Int. J. Clin. Exp. Med. 2015;8:16374\u201316378.", "ArticleIdList": ["PMC4659048", "26629160"]}, {"Citation": "Karran E., Mercken M., De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 2011;10:698\u2013712. doi: 10.1038/nrd3505.", "ArticleIdList": ["10.1038/nrd3505", "21852788"]}, {"Citation": "Hughes E.R., Nikolic K., Ramsay R.R. One for All? Hitting multiple Alzheimer\u2019s Ddisease targets with one drug. Front. Neurosci. 2016;10:177. doi: 10.3389/fnins.2016.00177.", "ArticleIdList": ["10.3389/fnins.2016.00177", "PMC4842778", "27199640"]}, {"Citation": "Nikolic K., Mavridis L., Djikic T., Vucicevic J., Agbaba D., Yelekci K., Mitchell J.B.O. Drug design for CNS diseases: Polypharmacological profiling of compounds using chemoinformatic, 3D-QSAR and virtual screening methodologies. Front. Neurosci. 2016;10:265. doi: 10.3389/fnins.2016.00265.", "ArticleIdList": ["10.3389/fnins.2016.00265", "PMC4901078", "27375423"]}, {"Citation": "Wang L., Ma C., Wipf P., Liu H., Su W., Xie X.Q. Target hunter: An in-silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J. 2013;15:395\u2013406. doi: 10.1208/s12248-012-9449-z.", "ArticleIdList": ["10.1208/s12248-012-9449-z", "PMC3675739", "23292636"]}, {"Citation": "Bautista-Aguilera O.M., Esteban G., Bolea I., Nikolic K., Agbaba D., Moraleda I., Iriepa I., Samadi A., Soriano E., Unzeta M., et al. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modelling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 2014;75:82\u201395. doi: 10.1016/j.ejmech.2013.12.028.", "ArticleIdList": ["10.1016/j.ejmech.2013.12.028", "24530494"]}, {"Citation": "Bautista-Aguilera O.M., Samadi A., Chioua M., Nikolic K., Filipic S., Agbaba D., Soriano E., de Andres L., Rodriguez-Franco M.I., Alcaro S., et al. N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)-piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual. J. Med. Chem. 2014;57:10455\u201310463. doi: 10.1021/jm501501a.", "ArticleIdList": ["10.1021/jm501501a", "25418133"]}, {"Citation": "Bolea I., Juarez-Jimenez J., de los Rios C., Chioua M., Pouplana R., Luque F.J., Unzeta M., Marco-Contelles J., Samadi A. Synthesis, biological evaluation, and molecular modelling of donepezil and N-(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer\u2019s disease. J. Med. Chem. 2011;54:8251\u20138270.", "ArticleIdList": ["22023459"]}, {"Citation": "Nikolic K., Mavridis L., Bautista-Aguilera O.M., Marco-Contelles J., Stark H., Carmo Carreiras M., Rossi I., Massarelli P., Agbaba D., Ramsay R.R., et al. Predicting targets of compounds against neurological diseases using cheminformatic methodology. J. Comput. Aided Mol. Des. 2015;29:183\u2013198. doi: 10.1007/s10822-014-9816-1.", "ArticleIdList": ["10.1007/s10822-014-9816-1", "25425329"]}, {"Citation": "Nikolic K., Agbaba D., Stark H. Pharmacophore modelling, drug design and virtual screening on multi-targeting precognitive agents approaching histaminergic pathways. J. Taiwan Inst. Chem. 2015;46:15\u201329. doi: 10.1016/j.jtice.2014.09.017.", "ArticleIdList": ["10.1016/j.jtice.2014.09.017"]}, {"Citation": "Jezova D., Herman J.P. Lessons from regular gathering of experts in stress research: Focus on pathophysiological consequences of stress exposure. Stress. 2016;19:339\u2013340. doi: 10.1080/10253890.2016.1213515.", "ArticleIdList": ["10.1080/10253890.2016.1213515", "27426742"]}, {"Citation": "Jezova D., Hlavacova N. Endocrine factors in stress and psychiatric disorders: Focus on anxiety and salivary steroids. Stress. 2008;1148:495\u2013503. doi: 10.1196/annals.1410.050.", "ArticleIdList": ["10.1196/annals.1410.050", "19120147"]}, {"Citation": "Prokopova B., Jezova D. Stress and possibilities of its pharmacological modulation\u2014Do we know to measure the stress load? Psychiatr. Praxi. 2013;14:150\u2013154."}, {"Citation": "Hlavacova N., Wes P.D., Ondrejcakova M., Flynn M.E., Poundstone P.K., Babic S., Murck H., Jezova D. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int. J. Neuropsychopharmacol. 2012;15:247\u2013265. doi: 10.1017/S1461145711000368.", "ArticleIdList": ["10.1017/S1461145711000368", "21375792"]}, {"Citation": "Hlavacova N., Solarikova P., Marko M., Brezina I., Jezova D. Blunted cortisol response to psychosocial stress in atopic patients is associated with decreasein salivary alpha-amylase and aldosterone: Focus on sex and menstrual cycle phase. Psychoneuroendocrinology. 2017;78:31\u201338. doi: 10.1016/j.psyneuen.2017.01.007.", "ArticleIdList": ["10.1016/j.psyneuen.2017.01.007", "28152431"]}, {"Citation": "Segeda V., Izakova L., Hlavacova N., Bednarova A., Jezova D. Aldosterone concentrations in saliva reflect the duration and severity of depressive episode in a sex dependent manner. J. Psychiatr. Res. 2017;91:164\u2013168. doi: 10.1016/j.jpsychires.2017.04.011.", "ArticleIdList": ["10.1016/j.jpsychires.2017.04.011", "28477530"]}, {"Citation": "Sichrovska B., Malik I., Sedlarova E., Csollei J., Muselik J. In vitro antioxidant properties of novel \u03b23-adrenoceptor agonists bearing benzenesulfonamide fragment. Dhaka Univ. J. Pharm. Sci. 2013;12:23\u201328. doi: 10.3329/dujps.v12i1.16296.", "ArticleIdList": ["10.3329/dujps.v12i1.16296"]}, {"Citation": "Sichrovska-Havranova L. Ph.D. Thesis. Faculty of Pharmacy, Comenius University in Bratislava; Bratislava, Slovakia: 2014. Preparation, Study of Physico-Chemical Properties and Biological Activity of Compounds with Potential Agonistic Effect on Beta Adrenergic Receptors."}, {"Citation": "Csanova A., Hlavacova N., Hasiec M., Pokusa M., Prokopova B., Jezova D. \u03b23-Adrenergic receptors, adipokines and neuroendocrine activation during stress induced by repeated immune challenge in male and female rats. Stress. 2017;20:294\u2013302. doi: 10.1080/10253890.2017.1320387.", "ArticleIdList": ["10.1080/10253890.2017.1320387", "28412873"]}, {"Citation": "Tsopelas F., Giaginis C., Tsantili-Kakoulidou A. Lipophilicity and biomimetic properties to support drug discovery. Exp. Opin. Drug Discov. 2017;12:885\u2013896. doi: 10.1080/17460441.2017.1344210.", "ArticleIdList": ["10.1080/17460441.2017.1344210", "28644732"]}, {"Citation": "Vrakas D., Giaginis C., Tsantili-Kakoulidou A. Electrostatic interactions and ionization effect in IAM retention. A comparative study with octanol-water partitioning. J. Chromatogr. A. 2008;1187:67\u201378. doi: 10.1016/j.chroma.2008.01.079.", "ArticleIdList": ["10.1016/j.chroma.2008.01.079", "18291408"]}, {"Citation": "Tsopelas F., Vallianatou T., Tsantili-Kakoulidou A. The potential of immobilized artificial membrane chromatography to predict human oral absorption. Eur. J. Pharm. Sci. 2016;81:82\u201393. doi: 10.1016/j.ejps.2015.09.020.", "ArticleIdList": ["10.1016/j.ejps.2015.09.020", "26485055"]}, {"Citation": "De Vrieze M., Janssens P., Szucs R., Van der Eycken J., Lynen F. In vitro prediction of human intestinal absorption and blood-brain barrier partitioning: Development of a lipid analog for micellar liquid chromatography. Anal. Bioanal. Chem. 2015;407:7453\u20137466. doi: 10.1007/s00216-015-8911-z.", "ArticleIdList": ["10.1007/s00216-015-8911-z", "26277183"]}, {"Citation": "Chrysanthakopoulos M., Giaginis C., Tsantili-Kakoulidou A. Retention of structurally diverse drugs in human serum albumin chromatography and its potential to simulate plasma protein binding. J. Chromatogr. A. 2010;1217:5761\u20135768. doi: 10.1016/j.chroma.2010.07.023.", "ArticleIdList": ["10.1016/j.chroma.2010.07.023", "20691448"]}, {"Citation": "Chrysanthakopoulos M., Valianatou T., Giaginis C., Tsantili-Kakoulidou A. Investigation of the retention behavior of structurally diverse drugs on alpha1 acid glycoprotein column. Insight on the molecular factors involved and correlation with biological binding data. Eur. J. Pharm. Sci. 2014;60:24\u201331. doi: 10.1016/j.ejps.2014.04.015.", "ArticleIdList": ["10.1016/j.ejps.2014.04.015", "24800938"]}, {"Citation": "Hoppe B., Martens J. Aminos\u00e4uren\u2014Bausteine des Lebens. ChiuZ. 1983;17:41\u201353. doi: 10.1002/ciuz.19830170203.", "ArticleIdList": ["10.1002/ciuz.19830170203"]}, {"Citation": "Hoppe B., Martens J. Aminos\u00e4uren\u2014Herstellung und Gewinnung. ChiuZ. 1984;18:73\u201386. doi: 10.1002/ciuz.19840180302.", "ArticleIdList": ["10.1002/ciuz.19840180302"]}, {"Citation": "Wolman Y., Haverland W.J., Miller S.L. Non-protein amino acids from spark discharges and their comparison with the Murchison meteorite amino acids. Proc. Nat. Acad. Sci. USA. 1972;69:809\u2013811. doi: 10.1073/pnas.69.4.809.", "ArticleIdList": ["10.1073/pnas.69.4.809", "PMC426569", "16591973"]}, {"Citation": "Schurig V. Exploring chirality in outer space. Anal. Chem. TAS Issue 1215, 2015;35:36\u201341."}, {"Citation": "Bada J.L., Protsch R. Racemization reaction of aspartic acid and its use in dating fossil bones. Proc. Nat. Acad. Sci. USA. 1973;70:1331\u20131334. doi: 10.1073/pnas.70.5.1331.", "ArticleIdList": ["10.1073/pnas.70.5.1331", "PMC433490", "16592082"]}, {"Citation": "Bhushan R., Martens J. Amino Acids. HNB Publishing; New York, NY, USA: 2010. pp. 173\u2013286."}, {"Citation": "Sajewicz M., Kowalska T. Chiral thin layer chromatography in dynamic studies. A short review. J. Planar Chromatogr. Mod. TLC. 2017;30:333\u2013339. doi: 10.1556/1006.2017.30.5.1.", "ArticleIdList": ["10.1556/1006.2017.30.5.1"]}, {"Citation": "Sajewicz M., Dolnik M., Kowalska T., Epstein I.R. Condensation dynamics of L-proline and L-hydroxyproline in solution. RSC Adv. 2014;4:7330\u20137339. doi: 10.1039/C3RA46921B.", "ArticleIdList": ["10.1039/C3RA46921B"]}, {"Citation": "Maciejowska A., Godziek A., Talik E., Sajewicz M., Kowalska T., Epstein I.R. Spontaneous pulsation of peptide microstructures in an abiotic liquid system. J. Chromatogr. Sci. 2016;54:1301\u20131309. doi: 10.1093/chromsci/bmw073.", "ArticleIdList": ["10.1093/chromsci/bmw073", "27190310"]}, {"Citation": "Eur.  Monitoring Centre for Drugs and Drug Addiction.  [(accessed on 1 September 2017)]; Report 2015. Available online:  http://www.emcdda.europa.eu/edr2015."}, {"Citation": "Grasso G., Mielczarek P., Niedziolka M., Silberring J. Metabolism of cryptic peptides derived from neuropeptide FF precursors: The involvement of insulin-degrading enzyme. Int. J. Mol. Sci. 2014;15:16787\u201316799. doi: 10.3390/ijms150916787.", "ArticleIdList": ["10.3390/ijms150916787", "PMC4200852", "25247577"]}, {"Citation": "Smoluch M., Mielczarek P., Silberring J. Plasma-based ambient ionization mass spectrometry in bioanalytical sciences. Mass Spectrom. Rev. 2016;35:22\u201334. doi: 10.1002/mas.21460.", "ArticleIdList": ["10.1002/mas.21460", "25988731"]}, {"Citation": "Mielczarek P., Smoluch M., Kotlinska J.H., Labuz K., Gotszalk T., Babij M., Suder P., Silberring J. Electrochemical generation of selegiline metabolites coupled to mass spectrometry. J. Chromatogr. A. 2015;1389:96\u2013103. doi: 10.1016/j.chroma.2015.02.049.", "ArticleIdList": ["10.1016/j.chroma.2015.02.049", "25746755"]}, {"Citation": "Rendle D.F. X-ray diffraction in forensic science. Rigaku J. 2003;19:11\u201322."}, {"Citation": "Dutrow B., Clark C.M. Geochemical Instrumentation and Analysis: X-ray Powder Diffraction (PXRD)  [(accessed on 1 September 2017)]; Available online:  https://serc.carleton.edu/research_education/geochemsheets/techniques/XRD.html."}, {"Citation": "USP Pharmacopeial Convention . General. <941> Characterization of Crystalline and Partially Crystalline Solids by X-ray Powder Diffraction. USP Pharmacopeial Convention; Rockville, MD, USA: 2011."}, {"Citation": "International Centre for Diffraction Data . PDF-2. ICDD; Newtown Square, PA, USA: 2008."}, {"Citation": "Rojek B., Weso\u0142owski M. Thermal analysis of selected excipients used in the formulation process of medicinal products. Farm. Przegl. Nauk. 2010;9:45\u201350."}, {"Citation": "Szlezak N., Evers M., Wang J., P\u00e9rez L. The role of big data and advanced analytics in drug discovery, development, and commercialization. Clin. Pharmacol. Ther. 2014;95:492\u2013495. doi: 10.1038/clpt.2014.29.", "ArticleIdList": ["10.1038/clpt.2014.29", "24642713"]}, {"Citation": "Polanski J. Big data in structure-property studies\u2014From definitions to models. In: Leszczynski J., Roy K., editors. Advances in QSAR Modeling with Applications in Pharmaceutical, Chemical, Food, Agricultural, and Environmental Sciences. Springer; Berlin/Heidelberg, Germany: 2017. pp. 529\u2013552."}, {"Citation": "Hu Y., Bajorath J. Entering the \u2018big data\u2019 era in medicinal chemistry: Molecular promiscuity analysis revisited. Future Sci. OA. 2017;3:FSO179. doi: 10.4155/fsoa-2017-0001.", "ArticleIdList": ["10.4155/fsoa-2017-0001", "PMC5481856", "28670471"]}, {"Citation": "Polanski J., Kucia U., Duszkiewicz R., Kurczyk A., Magdziarz T., Gasteiger J. Molecular descriptor data explains market prices of the large commercial chemical compound library. Sci. Rep. 2016;6:28521. doi: 10.1038/srep28521.", "ArticleIdList": ["10.1038/srep28521", "PMC4917835", "27334348"]}, {"Citation": "Bickerton G.R., Paolini G.V., Besnard J., Muresan S., Hopkins A.L. Quantifying the chemical beauty of drugs. Nat. Chem. 2012;4:90\u201398. doi: 10.1038/nchem.1243.", "ArticleIdList": ["10.1038/nchem.1243", "PMC3524573", "22270643"]}, {"Citation": "Hopkins A.L., Keseru G.M., Leeson P.D., Rees D.C., Reynolds C.H. The role of ligand efficiency metrics in drug discovery. Nat. Rev. Drug Discov. 2014;13:105\u2013121. doi: 10.1038/nrd4163.", "ArticleIdList": ["10.1038/nrd4163", "24481311"]}, {"Citation": "Gleeson M.P., Hersey A., Montanari D., Overington J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat. Rev. Drug Discov. 2011;10:197\u2013208. doi: 10.1038/nrd3367.", "ArticleIdList": ["10.1038/nrd3367", "PMC6317702", "21358739"]}, {"Citation": "Swinney D.C., Anthony J. How were new medicines discovered. Nat. Rev. Drug Discov. 2011;10:507\u2013519. doi: 10.1038/nrd3480.", "ArticleIdList": ["10.1038/nrd3480", "21701501"]}, {"Citation": "Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there? Nat. Rev. Drug Discov. 2006;5:993\u2013996. doi: 10.1038/nrd2199.", "ArticleIdList": ["10.1038/nrd2199", "17139284"]}, {"Citation": "Polanski J., Tkocz A., Kucia U. Beware of ligand efciency (LE): Understanding LE data in modeling structure-activity and structure-economy relationships. J. Chemoinform. 2017;9:49. doi: 10.1186/s13321-017-0236-9.", "ArticleIdList": ["10.1186/s13321-017-0236-9", "PMC5593805", "29086197"]}, {"Citation": "Polanski J., Tkocz A. Between descriptors and properties: Understanding the ligand efficiency trends for G protein-coupled receptor and kinase structure-activity data sets. J. Chem. Inf. Model. 2017;26:1321\u20131329. doi: 10.1021/acs.jcim.7b00116.", "ArticleIdList": ["10.1021/acs.jcim.7b00116", "28489365"]}, {"Citation": "Goracci L., Tortorella S., Tiberi P., Pellegrino R.M., Di Veroli A., Valeri A., Cruciani G. Lipostar, a comprehensive platform-neutral cheminformatics tool for lipidomics. Anal. Chem. 2017;89:6257\u20136264. doi: 10.1021/acs.analchem.7b01259.", "ArticleIdList": ["10.1021/acs.analchem.7b01259", "28471643"]}, {"Citation": "Polanski J., Gasteiger J. Computer Representation of Chemical Compounds. In: Leszczynski J., Puzyn T., editors. Handbook of Computational Chemistry. Springer; Dordrecht, Germany: 2016. pp. 1\u201343."}]}], "History": [{"Year": "2017", "Month": "9", "Day": "29"}, {"Year": "2017", "Month": "10", "Day": "26"}, {"Year": "2017", "Month": "10", "Day": "26"}, {"Year": "2017", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["29143778", "PMC6150335", "10.3390/molecules22111848", "molecules22111848"]}}]}